Page last updated: 2024-10-19

oxamic acid and Burkitt Lymphoma

oxamic acid has been researched along with Burkitt Lymphoma in 1 studies

Oxamic Acid: Amino-substituted glyoxylic acid derivative.
oxamic acid : A dicarboxylic acid monoamide resulting from the formal condensation of one of the carboxy groups of oxalic acid with ammonia.

Burkitt Lymphoma: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manerba, M1
Di Ianni, L1
Fiume, L1
Roberti, M1
Recanatini, M1
Di Stefano, G1

Other Studies

1 other study available for oxamic acid and Burkitt Lymphoma

ArticleYear
Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2015, Jul-10, Volume: 74

    Topics: Antineoplastic Agents; Burkitt Lymphoma; Cell Line, Transformed; Cell Line, Tumor; Cell Survival; Ci

2015